Clinical Trial Update: DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

View source ↗

Summary

This clinical trial update profiles demographics and clinical characteristics of non-small cell lung cancer patients and analyzes guideline-concordant first-lin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Lung Neoplasms | Status: RECRUITING